by chuck_ltd | 7 Mar, 2017 | CHCUK News & Articles, EAP, Orphan Drugs, Rare Diseases, Real Word Evidence
PRIME (PRIority MEdicines) is a scheme launched by the European Medicines Agency (EMA) to enhance support for the development of medicines that target an unmet medical need. This voluntary scheme is based on enhanced interaction and early dialogue with developers of...
by chuck_ltd | 22 Dec, 2015 | CHCUK News & Articles, News, Reimbursement
This is the first in a series of articles in our Newsletters on pricing and reimbursement in the European Union. This article deals with the basic principles for pricing of medicinal products in the UK under the: voluntary scheme established by Pharmaceutical Price...
